X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/02/20/2831505/0/en/Philogen-provides-update-on-pre-planned-interim-analysis-of-the-Phase-III-FIBROSARC-trial-investigating-Onfekafusp-alfa-L19TNF-in-patients-with-first-line-advanced-or-metastatic-So.html
https://www.globenewswire.com/news-release/2023/12/05/2790613/0/en/Philogen-S-p-A-announces-receipt-of-the-Good-Manufacturing-Practice-Certificate-for-its-new-Production-facility-in-Rosia-Siena-Italy-by-Competent-Authorities.html
https://www.globenewswire.com//news-release/2023/12/04/2789729/0/en/Philochem-and-Blue-Earth-Diagnostics-Announce-First-Three-Patients-Imaged-in-Phase-1-Clinical-Trial-of-68Ga-OncoFAP-68Ga-OncoFAP-DOTAGA-for-Diagnostic-Imaging-in-Solid-Tumors.html
https://www.globenewswire.com//news-release/2023/10/16/2760644/0/en/Nidlegy-Phase-III-PIVOTAL-trial-meets-the-study-s-primary-objective-demonstrating-statistically-significant-and-clinically-meaningful-improvement-in-Recurrence-Free-Survival-for-pa.html
https://www.globenewswire.com/news-release/2023/06/28/2695916/0/en/Philogen-enters-into-a-Service-and-Supply-Agreement-with-IBSA-for-the-GMP-Production-of-a-Therapeutic-Protein.html
https://www.globenewswire.com/news-release/2023/06/01/2679977/0/en/Philogen-Announces-Clinical-Trial-Collaboration-with-MSD.html
https://www.pharmaceutical-technology.com/news/sun-pharma-philogen-nidlegy/
https://www.globenewswire.com/news-release/2023/05/25/2675821/0/en/Philogen-Publishes-New-Data-on-a-Fibromun-based-treatment-combination-in-Science-Translational-Medicine-in-collaboration-with-the-University-Hospital-Z%C3%BCrich.html
https://www.globenewswire.com/news-release/2023/03/28/2635346/0/en/Philogen-Announces-Publication-of-a-New-Study-in-Collaboration-with-Google-focused-on-Machine-Learning-models-applied-to-DNA-Encoded-Chemical-Library-Technology.html
https://www.globenewswire.com//news-release/2022/12/01/2565566/0/en/Philogen-Provides-Corporate-Update.html
Market Place
Share 
